Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Why Index Levels Matter explains the impact of index readings on market perception and strategy, guiding you to smarter investment choices.
23,403 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
NVIDIA CEO Jensen Huang challenges the AI jobs doomsayers narrative as the company posts blockbuster revenue driven b...
A dramatic daily swing has SpaceX briefly tumbling below Amazon in market cap. Here's how to judge which growth stock...
As firms accelerate AI use, the hidden cost your rollout is exposing becomes clearer: burnout among the very employee...
Inflation stays elevated as June 2026 data roll in, shaping budgets and investment plans. This piece explains what co...
SpaceX saw a sharp weekly decline as bond-market concerns weighed on sentiment. Analysts flag Starlink expansion, AI ...
Cardano’s wallet breach drama centers on an unresolved mystery: nobody knows stole $18.5M in ADA as officials push fo...
Microsoft shares have fallen sharply this year, yet bulls argue that cloud growth and AI initiatives underpin a resil...
Bitwise CIO Matt Hougan argues that Strategy's STRC selloff reflects end-of-cycle deleveraging preceding a bitcoin bo...
Two retirees with the same income saw different Medicare costs in 2026 when one filed a life-changing-event form. The...
As oil markets swing, Noble and Transocean stand out in the offshore drilling arena. This guide breaks down which off...
Berkshire Hathaway’s cash pile nears the $400 billion mark, renewing scrutiny on what the conglomerate will do with v...